BCDA
Price
$2.06
Change
+$0.02 (+0.98%)
Updated
Sep 5 closing price
Capitalization
11.95M
SBMFF
Price
$0.99
Change
+$0.04 (+4.21%)
Updated
Aug 13 closing price
Capitalization
20.43B
Interact to see
Advertisement

BCDA vs SBMFF

Header iconBCDA vs SBMFF Comparison
Open Charts BCDA vs SBMFFBanner chart's image
BioCardia
Price$2.06
Change+$0.02 (+0.98%)
Volume$28.38K
Capitalization11.95M
Sino Biopharmaceutical
Price$0.99
Change+$0.04 (+4.21%)
Volume$132
Capitalization20.43B
BCDA vs SBMFF Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. SBMFF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongBuy and SBMFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCDA: $2.04 vs. SBMFF: $0.99)
Brand notoriety: BCDA and SBMFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 5% vs. SBMFF: 3%
Market capitalization -- BCDA: $11.95M vs. SBMFF: $20.43B
BCDA [@Biotechnology] is valued at $11.95M. SBMFF’s [@Biotechnology] market capitalization is $20.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSBMFF’s FA Score has 2 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SBMFF’s FA Score: 2 green, 3 red.
According to our system of comparison, SBMFF is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while SBMFF’s TA Score has 3 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 5 bearish.
  • SBMFF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, SBMFF is a better buy in the short-term than BCDA.

Price Growth

BCDA (@Biotechnology) experienced а +4.08% price change this week, while SBMFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBMFF($20.4B) has a higher market cap than BCDA($12M). SBMFF YTD gains are higher at: 140.481 vs. BCDA (-5.505). SBMFF has higher annual earnings (EBITDA): 6.98B vs. BCDA (-8.81M). SBMFF has higher revenues than BCDA: SBMFF (26.2B) vs BCDA (0).
BCDASBMFFBCDA / SBMFF
Capitalization12M20.4B0%
EBITDA-8.81M6.98B-0%
Gain YTD-5.505140.481-4%
P/E RatioN/A32.66-
Revenue026.2B-
Total Cash980KN/A-
Total Debt745KN/A-
FUNDAMENTALS RATINGS
BCDA vs SBMFF: Fundamental Ratings
BCDA
SBMFF
OUTLOOK RATING
1..100
1024
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6136
P/E GROWTH RATING
1..100
10022
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBMFF's Valuation (2) in the null industry is significantly better than the same rating for BCDA (88). This means that SBMFF’s stock grew significantly faster than BCDA’s over the last 12 months.

SBMFF's Profit vs Risk Rating (100) in the null industry is in the same range as BCDA (100). This means that SBMFF’s stock grew similarly to BCDA’s over the last 12 months.

SBMFF's SMR Rating (96) in the null industry is in the same range as BCDA (100). This means that SBMFF’s stock grew similarly to BCDA’s over the last 12 months.

SBMFF's Price Growth Rating (36) in the null industry is in the same range as BCDA (61). This means that SBMFF’s stock grew similarly to BCDA’s over the last 12 months.

SBMFF's P/E Growth Rating (22) in the null industry is significantly better than the same rating for BCDA (100). This means that SBMFF’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASBMFF
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 24 days ago
48%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCLX22.802.42
+11.87%
Scilex Holding Company
PCH42.870.67
+1.59%
PotlatchDeltic Corp
MMA0.84N/A
N/A
Mixed Martial Arts Group Limited
CAC40.56-0.46
-1.12%
Camden National Corp
TROW108.16-3.36
-3.01%
T Rowe Price Group

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+0.98%
SMMT - BCDA
68%
Closely correlated
+9.16%
XRTX - BCDA
43%
Loosely correlated
+1.85%
MDGL - BCDA
29%
Poorly correlated
+0.39%
INO - BCDA
28%
Poorly correlated
+1.45%
KOD - BCDA
28%
Poorly correlated
+23.04%
More

SBMFF and

Correlation & Price change

A.I.dvisor tells us that SBMFF and PSTV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBMFF and PSTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBMFF
1D Price
Change %
SBMFF100%
N/A
PSTV - SBMFF
22%
Poorly correlated
-2.22%
BCDA - SBMFF
21%
Poorly correlated
N/A
INKT - SBMFF
21%
Poorly correlated
-2.31%
ALZN - SBMFF
20%
Poorly correlated
-3.81%
LYEL - SBMFF
20%
Poorly correlated
+2.54%
More